Company Description

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expert-based contract research, consulting, medical communications, and technology solutions to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the devel... More >>

Q4 2016 Quarterly ResultsMore Info >>
Earnings Press Release
 Form 8-K
Q4 Financial Results and Trended Information

Recent NewsMore Info >>
PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results
PAREXEL International Announces Date of Fourth Quarter and Fiscal Year 2016 Earnings Release and Conference Call
PAREXEL International Outlines Growth Strategy And Updates Financial Guidance At Investor Day

EventsMore Info >>
PAREXEL International Investor Day 2016
Thursday, June 30, 2016 9:00 a.m. ET
Supporting Materials
Download Event Supporting Material PAREXEL’s 2016 Investor Day Presentation